These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 26041736)

  • 1. Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy.
    Holtzhausen A; Zhao F; Evans KS; Tsutsui M; Orabona C; Tyler DS; Hanks BA
    Cancer Immunol Res; 2015 Sep; 3(9):1082-95. PubMed ID: 26041736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization.
    Zhao F; Xiao C; Evans KS; Theivanthiran T; DeVito N; Holtzhausen A; Liu J; Liu X; Boczkowski D; Nair S; Locasale JW; Hanks BA
    Immunity; 2018 Jan; 48(1):147-160.e7. PubMed ID: 29343435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.
    Sharma MD; Baban B; Chandler P; Hou DY; Singh N; Yagita H; Azuma M; Blazar BR; Mellor AL; Munn DH
    J Clin Invest; 2007 Sep; 117(9):2570-82. PubMed ID: 17710230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted siRNA silencing of indoleamine 2, 3-dioxygenase in antigen-presenting cells using mannose-conjugated liposomes: a novel strategy for treatment of melanoma.
    Chen D; Koropatnick J; Jiang N; Zheng X; Zhang X; Wang H; Yuan K; Siu KS; Shunnar A; Way C; Min WP
    J Immunother; 2014; 37(2):123-34. PubMed ID: 24509175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients.
    Roy S; Barik S; Banerjee S; Bhuniya A; Pal S; Basu P; Biswas J; Goswami S; Chakraborty T; Bose A; Baral R
    Hum Immunol; 2013 Aug; 74(8):1015-23. PubMed ID: 23628394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression.
    Wobser M; Voigt H; Houben R; Eggert AO; Freiwald M; Kaemmerer U; Kaempgen E; Schrama D; Becker JC
    Cancer Immunol Immunother; 2007 Jul; 56(7):1017-24. PubMed ID: 17195079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression.
    Plebanek MP; Xue Y; Nguyen YV; DeVito NC; Wang X; Holtzhausen A; Beasley GM; Theivanthiran B; Hanks BA
    Sci Immunol; 2024 May; 9(95):eadi4191. PubMed ID: 38728412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.
    Kahler DJ; Mellor AL
    Handb Exp Pharmacol; 2009; (188):165-96. PubMed ID: 19031026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of melanoma-induced sentinel lymph node immune dysfunction.
    Lee JH; Chen Y; Chan JL; Qian YW; Goydos JS
    Cancer Immunol Immunother; 2011 May; 60(5):685-92. PubMed ID: 21327637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis.
    Orabona C; Pallotta MT; Volpi C; Fallarino F; Vacca C; Bianchi R; Belladonna ML; Fioretti MC; Grohmann U; Puccetti P
    Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20828-33. PubMed ID: 19088199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt-β-Catenin Signaling in Human Dendritic Cells Mediates Regulatory T-Cell Responses to Fungi via the PD-L1 Pathway.
    Karnam A; Bonam SR; Rambabu N; Wong SSW; Aimanianda V; Bayry J
    mBio; 2021 Dec; 12(6):e0282421. PubMed ID: 34781737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction.
    Matteoli G; Mazzini E; Iliev ID; Mileti E; Fallarino F; Puccetti P; Chieppa M; Rescigno M
    Gut; 2010 May; 59(5):595-604. PubMed ID: 20427394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions.
    Onodera T; Jang MH; Guo Z; Yamasaki M; Hirata T; Bai Z; Tsuji NM; Nagakubo D; Yoshie O; Sakaguchi S; Takikawa O; Miyasaka M
    J Immunol; 2009 Nov; 183(9):5608-14. PubMed ID: 19843945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the Regulatory T-Cell/Indoleamine 2,3-Dioxygenase Axis Reduces Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice.
    Forteza MJ; Polyzos KA; Baumgartner R; Suur BE; Mussbacher M; Johansson DK; Hermansson A; Hansson GK; Ketelhuth DFJ
    Front Immunol; 2018; 9():950. PubMed ID: 29867939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.
    Chung DJ; Rossi M; Romano E; Ghith J; Yuan J; Munn DH; Young JW
    Blood; 2009 Jul; 114(3):555-63. PubMed ID: 19465693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt5a skews dendritic cell differentiation to an unconventional phenotype with tolerogenic features.
    Valencia J; Hernández-López C; Martínez VG; Hidalgo L; Zapata AG; Vicente Á; Varas A; Sacedón R
    J Immunol; 2011 Oct; 187(8):4129-39. PubMed ID: 21918189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment.
    Hanks BA; Holtzhausen A; Evans KS; Jamieson R; Gimpel P; Campbell OM; Hector-Greene M; Sun L; Tewari A; George A; Starr M; Nixon AB; Augustine C; Beasley G; Tyler DS; Osada T; Morse MA; Ling L; Lyerly HK; Blobe GC
    J Clin Invest; 2013 Sep; 123(9):3925-40. PubMed ID: 23925295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma.
    Han Y; Chen Z; Yang Y; Jiang Z; Gu Y; Liu Y; Lin C; Pan Z; Yu Y; Jiang M; Zhou W; Cao X
    Hepatology; 2014 Feb; 59(2):567-79. PubMed ID: 23960017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4.
    Holmgaard RB; Zamarin D; Munn DH; Wolchok JD; Allison JP
    J Exp Med; 2013 Jul; 210(7):1389-402. PubMed ID: 23752227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients.
    Speeckaert R; Vermaelen K; van Geel N; Autier P; Lambert J; Haspeslagh M; van Gele M; Thielemans K; Neyns B; Roche N; Verbeke N; Deron P; Speeckaert M; Brochez L
    Eur J Cancer; 2012 Sep; 48(13):2004-11. PubMed ID: 22033321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.